| Product NDC: | 0037-5005 |
| Proprietary Name: | Demadex |
| Non Proprietary Name: | Torsemide |
| Active Ingredient(s): | 5 mg/1 & nbsp; Torsemide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0037-5005 |
| Labeler Name: | Meda Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020136 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090220 |
| Package NDC: | 0037-5005-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (0037-5005-01) |
| NDC Code | 0037-5005-01 |
| Proprietary Name | Demadex |
| Package Description | 100 TABLET in 1 BOTTLE (0037-5005-01) |
| Product NDC | 0037-5005 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Torsemide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20090220 |
| Marketing Category Name | NDA |
| Labeler Name | Meda Pharmaceuticals Inc. |
| Substance Name | TORSEMIDE |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC] |